Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients

Scandinavian Journal of Urology and Nephrology

Volumn 39, Issue 5, 2005, Pages 405-409

  Seyrek, Neslihan ^a   Karayaylali, Ibrahim ^a   Balal, Mustafa ^a   Paydas, Saime ^a   Aikimbaev, Kairgueldi ^a   Cetiner, Salih ^a   Seydaoglu, Gulsah ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Hemodialysis; High sensitivity C reactive protein; Inflammation; Interleukin 10

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER FLOWMETRY; EVALUATION; FEMALE; GENDER; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS;

EID: 27944452740     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590500386734     Document Type: Article

References (13)

1. US Renal Data System. Causes of death: Annual Data Report No. 14. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1995. p. 79-90.
2. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-911.
3. Girndt M, Sester U, Kaul H, Köhler H. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single cell level. J Am Soc Nephrol 1988; 9:1689-96.
4. Tetta C, Gallieni M, Panichi V, Brancacciom D. Vascular calcifications as a footprint of increased calcium load and chronic inflammation in uremic patients: a need for a neutral calcium balance during hemodialysis? Int J Artif Org 2002; 25:18-25.
5. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
6. Mehta JL, Salden T, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31: 1217-25.
7. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11:165-90.
8. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-58.
9. Ceung AK, Sarnak MJ, Van G, Dwyer JT, Heyka RJ, Rocco MV, et al. Atherosclerotic cardiovascular disease risk in chronic hemodialysis patients. Kidney Int 2000;58:353-62.
10. Santoro A, Mancini E. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant 2002;17: 10-5.
11. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersire E, Kimoons ML, et al. Serum level of anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003;107:2109-14.
12. Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int 2002;61:99-102.
13. Girndt M, Kaul H, Sester U, Ulrich C, Sester MM, Georg T, et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002;62:949-55.